234 related articles for article (PubMed ID: 22935165)
1. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
2. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
5. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
6. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
9. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
10. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
11. Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.
Shimizu J; Takai K; Takada E; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Suzuki T; Suzuki N
Clin Rheumatol; 2016 Jul; 35(7):1857-63. PubMed ID: 25972082
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
[TBL] [Abstract][Full Text] [Related]
13. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
[TBL] [Abstract][Full Text] [Related]
14. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.
Nagafuchi H; Takeno M; Yoshikawa H; Kurokawa MS; Nara K; Takada E; Masuda C; Mizoguchi M; Suzuki N
Clin Exp Immunol; 2005 Feb; 139(2):363-70. PubMed ID: 15654836
[TBL] [Abstract][Full Text] [Related]
15. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.
Suzuki N; Nara K; Suzuki T
Clin Med Res; 2006 Jun; 4(2):147-51. PubMed ID: 16809408
[TBL] [Abstract][Full Text] [Related]
16. Increased Notch pathway activation in Behçet's disease.
Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
[TBL] [Abstract][Full Text] [Related]
17. Activation of the JAK/STAT pathway in Behcet's disease.
Tulunay A; Dozmorov MG; Ture-Ozdemir F; Yilmaz V; Eksioglu-Demiralp E; Alibaz-Oner F; Ozen G; Wren JD; Saruhan-Direskeneli G; Sawalha AH; Direskeneli H
Genes Immun; 2015 Mar; 16(2):170-5. PubMed ID: 25410656
[TBL] [Abstract][Full Text] [Related]
18. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease.
Ben Ahmed M; Houman H; Miled M; Dellagi K; Louzir H
Arthritis Rheum; 2004 Jul; 50(7):2291-5. PubMed ID: 15248229
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.
Hamedi M; Bergmeier LA; Hagi-Pavli E; Vartoukian SR; Fortune F
Scand J Immunol; 2014 Nov; 80(5):369-76. PubMed ID: 25207681
[TBL] [Abstract][Full Text] [Related]
20. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
